PAVmed (PAVM) Stock Chart & Stock Price History $1.09 +0.07 (+6.86%) (As of 11/14/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PAVmed Stock Price Performance5 Day Performance-1.80%1 Month Performance+7.92%3 Month Performance+55.49%6 Month Performance-42.63%Year-To-Date Performance-73.54%1 Year Performance-67.12% Receive PAVM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. PAVM Stock Chart for Friday, November, 15, 2024 PAVM Chart by TradingView PAVmed Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/14/2024$1.02$1.09+6.86%$1.12$1.01131,241 shs$11.34 million11/13/2024$1.12$1.02-8.93%$1.19$1.0245,448 shs$10.61 million11/12/2024$1.12$1.12$1.21$1.1184,785 shs$11.66 million11/11/2024$1.11$1.12+0.90%$1.14$1.0934,077 shs$11.66 million11/08/2024$1.06$1.12+6.16%$1.12$1.0457,920 shs$11.66 million11/07/2024$1.04$1.06+1.93%$1.08$1.0344,715 shs$10.98 million Get the Latest News and Ratings for PAVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. 11/06/2024$1.06$1.04-2.36%$1.10$1.0216,544 shs$10.77 million11/05/2024$1.05$1.06+0.95%$1.09$1.0221,980 shs$11.03 million11/04/2024$1.03$1.05+2.24%$1.08$1.0215,400 shs$10.93 million11/01/2024$1.07$1.03-4.02%$1.08$1.0314,564 shs$10.69 million10/31/2024$1.05$1.07+1.90%$1.09$1.0513,522 shs$10.09 million10/30/2024$1.06$1.05-0.94%$1.11$1.0517,961 shs$9.90 million10/29/2024$1.11$1.06-4.50%$1.12$1.0620,297 shs$10.00 million10/28/2024$1.07$1.11+3.74%$1.12$1.0825,347 shs$10.47 million10/25/2024$1.00$1.07+7.00%$1.11$1.0344,565 shs$11.14 million10/24/2024$1.07$1.00-6.54%$1.11$1.0031,279 shs$10.41 million10/23/2024$1.08$1.07-0.93%$1.10$1.069,665 shs$11.14 million10/22/2024$1.09$1.08-0.46%$1.12$1.0523,122 shs$10.19 million10/21/2024$1.04$1.09+4.33%$1.10$1.0638,671 shs$10.23 million10/18/2024$1.03$1.04+0.97%$1.07$1.0130,849 shs$9.81 million10/17/2024$1.04$1.03-0.96%$1.07$1.0018,246 shs$9.72 million10/16/2024$1.01$1.04+2.97%$1.06$0.9935,758 shs$9.81 million10/15/2024$1.10$1.01-8.18%$1.09$0.9934,577 shs$9.53 million10/14/2024$1.16$1.10-5.17%$1.21$1.0615,898 shs$10.38 million10/11/2024$1.17$1.16-0.85%$1.22$1.1417,006 shs$12.08 million10/10/2024$1.25$1.17-6.40%$1.26$1.1448,803 shs$11.04 million10/09/2024$1.20$1.25+4.17%$1.29$1.2120,081 shs$11.79 million10/08/2024$1.19$1.20+0.84%$1.26$1.1739,231 shs$12.49 million10/07/2024$1.27$1.19-6.30%$1.28$1.1340,772 shs$12.39 million10/04/2024$1.30$1.27-1.93%$1.32$1.2113,851 shs$13.22 million10/03/2024$1.25$1.30+3.60%$1.31$1.2524,681 shs$13.48 million10/02/2024$1.33$1.25-6.02%$1.28$1.1861,989 shs$11.79 million10/01/2024$1.23$1.33+8.13%$1.45$1.2154,681 shs$12.55 million09/30/2024$1.17$1.23+5.13%$1.26$1.1558,890 shs$12.80 million09/27/2024$1.16$1.17+0.86%$1.17$1.1030,960 shs$11.04 million09/26/2024$1.15$1.16+0.87%$1.17$1.1413,398 shs$12.08 million09/25/2024$1.28$1.15-10.16%$1.33$1.1333,627 shs$11.97 million09/24/2024$1.29$1.28-0.78%$1.32$1.1631,943 shs$12.07 million09/23/2024$1.61$1.29-19.88%$1.53$1.2580,915 shs$12.17 million09/20/2024$1.65$1.61-2.42%$1.76$1.5450,304 shs$15.19 millionWar on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.09/19/2024$1.63$1.65+1.23%$1.67$1.6024,966 shs$15.56 million09/18/2024$1.73$1.63-5.51%$1.77$1.4557,626 shs$15.37 million09/17/2024$1.77$1.73-2.54%$1.76$1.6887,794 shs$16.27 million09/16/2024$1.78$1.77-0.56%$1.90$1.5969,462 shs$18.43 million09/13/2024$1.72$1.78+3.53%$1.83$1.66105,597 shs$18.53 million09/12/2024$1.58$1.72+8.82%$1.72$1.5479,303 shs$16.22 million09/11/2024$1.71$1.58-7.60%$1.88$1.45273,480 shs$16.45 million09/10/2024$1.19$1.71+43.70%$1.74$1.18320,466 shs$17.80 million09/09/2024$1.09$1.19+9.17%$1.26$1.0741,128 shs$12.39 million09/06/2024$1.16$1.09-6.03%$1.17$1.0732,362 shs$11.35 million09/05/2024$1.10$1.16+5.45%$1.17$1.0714,563 shs$12.08 million09/04/2024$1.19$1.10-7.31%$1.32$1.06239,169 shs$10.38 million09/03/2024$0.91$1.19+30.42%$1.20$0.91404,826 shs$11.19 million09/02/2024$0.91$0.91$0.92$0.84108,600 shs$9.47 million08/30/2024$0.84$0.91+8.29%$0.92$0.84108,006 shs$8.58 million08/29/2024$0.88$0.84-4.05%$0.88$0.8088,025 shs$7.93 million08/28/2024$0.91$0.88-3.76%$0.99$0.8399,798 shs$8.26 million08/27/2024$0.81$0.91+12.35%$0.97$0.81106,960 shs$8.58 million08/26/2024$0.74$0.81+10.20%$0.82$0.70120,791 shs$7.64 million08/23/2024$0.68$0.74+7.42%$0.74$0.7046,470 shs$7.65 million08/22/2024$0.73$0.68-6.20%$0.73$0.6844,007 shs$6.45 million08/21/2024$0.72$0.73+1.31%$0.74$0.6852,489 shs$6.88 million08/20/2024$0.69$0.72+4.35%$0.72$0.6832,154 shs$7.50 million08/19/2024$0.68$0.69+1.62%$0.71$0.6745,210 shs$7.18 million08/16/2024$0.70$0.69-1.57%$0.71$0.6632,420 shs$6.51 million08/15/2024$0.72$0.70-2.63%$0.74$0.6879,898 shs$6.61 million08/14/2024$0.74$0.72-2.72%$0.74$0.7040,247 shs$6.79 million Related Companies Allurion Technologies Stock Chart Outset Medical Stock Chart Bellevue Life Sciences Acquisition Stock Chart Envoy Medical Stock Chart Nexalin Technology Stock Chart Co-Diagnostics Stock Chart SurgePays Stock Chart BioSig Technologies Stock Chart Precision Optics Stock Chart DarioHealth Stock Chart Receive PAVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PAVmed and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PAVM) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
